Search clinical trials for: Schweres akutes respiratorisches Syndrom (SARS)

Total 42232 results

Cambridge Health Alliance
The Thoracic Foundation; Alturix

Not yet recruiting

NAC for Attenuation of COVID-19 Symptomatology (NACinCOVID2)

Covid19 | Oxidative Stress | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Respiratory Infection | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | COVID-19 Lower Respiratory Infection

United States
University Hospital, Geneva
University Hospital, Basel, Switzerland; Hôpital Fribourgeois; Ospedale Regionale...

Recruiting

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Covid19 | Old Age; Debility | Immuno-Deficiency

Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

Investigating Severe Acute Respiratory Syndrome (SARS)

SARS Virus

United States
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Goethe University
Nationwide Network of University Medicine (NUM) on Covid-19

Recruiting

Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) (SUEP-NAPKON)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Germany
Medical University of Graz
Medical University Innsbruck; Austrian Science Fund (FWF); AGES

Completed

Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria (SARIVA)

COVID-19

Austria
Azienda Ospedaliera Universitaria Integrata Verona
Charite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaborators

Recruiting

Follow-up of Covid-19 Long Term Sequelae

Coronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditions

Italy, Belgium, Congo, France, Netherlands, Spain
Pfizer

Completed

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

COVID-19

United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
Certara
Bill and Melinda Gates Foundation; Parexel

Completed

International Registry of Healthcare Workers Exposed to COVID-19 Patients (UNITY Global) (UNITY Global)

Covid19 | SARS-CoV Infection

Pakistan
Stemirna Therapeutics

Active, not recruiting

mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Efficacy | Safety | Immunogenicity

Lao People's Democratic Republic
University of Campania "Luigi Vanvitelli"

Completed

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

Non-Alcoholic Fatty Liver Disease

Italy
Imam Abdulrahman Bin Faisal University
Dammam Medical Complex; Institute for Research and medical consultations (IRMC)

Unknown

Antibodies Responses to COVID-19 Infection in Hospitalized Patients (No-SARS)

Hospitalized Patients | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection) | Laboratory-confirmed SARS-CoV 2 Infection

Saudi Arabia
Institute of Biomedical Technologies-National Research...
University of Milan; National Research Council, Institute of Clinical Physiology... and other collaborators

Completed

Italian Web-based Cross-sectional Survey on COVID-19 (EPICOVID19)

Covid19 | SARS-CoV Infection | Epidemic Disease | Self-Assessment | Survey, Family Life

Italy
M.D. Anderson Cancer Center

Active, not recruiting

Viral Specific T Cell Therapy for COVID-19 Related Pneumonia

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
University of Vic - Central University of Catalonia
Catalan Board of Physiotherapists

Enrolling by invitation

Lung Function in Post-COVID-19 Nursing Home Residents

Post-COVID-19 Syndrome

Spain
Cambridge Health Alliance

Completed

Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

COVID | Oxidative Stress | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere

United States
LumiraDx UK Limited

Suspended

Performance Evaluation of the LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B Tests at Point of Care (POC) Sites (PURSUE)

COVID-19 | SARS-CoV-2 | Influenza A | Influenza B

United States
OSF Healthcare System

Terminated

Observational Study of COVID-19 Treatment Efficacy

COVID-19 | Coronavirus Infection | COVID | Corona Virus Infection | Coronavirus | Sars-CoV2 | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | Coronavirus Disease | Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere | Coronavirus as the Cause of Diseases Classified...

United States
Evidation Health
Eli Lilly and Company; United States Department of Defense; Bill and Melinda... and other collaborators

Completed

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Covid19 | SARS-CoV Infection

United States
Ina-Respond
Center for Research and Development of Health Resources and Services, National...

Recruiting

Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia (FVR)

Covid19 | Infectious Disease | SARS-CoV Infection

Indonesia
University of Witwatersrand, South Africa
SynaVir

Completed

Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19 (DuACT)

Covid19 | SARS-CoV Infection

South Africa
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
AIM ImmunoTech Inc.

Completed

Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

Severe Acute Respiratory Syndrome

Hong Kong
Imperial College London
Royal Free Hospital NHS Foundation Trust; Hvivo

Completed

SARS-CoV-2 Human Challenge Characterisation Study

COVID-19 | Covid19 | Corona Virus Infection | SARS-CoV Infection | Coronavirus

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Convalescent SARS Plasma by Apheresis

Severe Acute Respiratory Syndrome | SARS

China
LumiraDx UK Limited

Completed

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19 (INSPIRE-2)

COVID-19 | Influenza A | RSV Infection | Influenza Type B

United States
Stemirna Therapeutics

Not yet recruiting

A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

Safety | Immunogenicity
Frontier Biotechnologies Inc.

Recruiting

Evaluate the Efficacy and Safety of FB2001 in Hospitalized Patients With Moderate to Severe COVID-19 (BRIGHT Study)

COVID-19

China
Kafrelsheikh University

Unknown

Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)

Covid19
FibroGen

Terminated

Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease

COVID-19

United States
Universidade Nova de Lisboa

Recruiting

COVID-19 and Pregnancy Outcomes (COVID&PREG)

Coronavirus Infection | Pregnancy Complications | Breastfeeding | Neonatal Infection | Vertical Transmission of Infectious Disease

Portugal
University Hospital, Montpellier

Recruiting

Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database (CovPCR)

Covid-19 | SARS-CoV Infection

France
AUVA
Paracelsus Medical University

Completed

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

Coronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2

Austria
Universidad de la Sabana

Not yet recruiting

Characterization Immunology, Biochemical and Lung Microbiome, Correlated With the Ventilation Associated Pneumonia (VAP) (MicroNAV-II)

Covid19 | SARS-CoV Infection

Colombia
Pfizer

Completed

EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19

COVID-19

United States, Korea, Republic of, Russian Federation, Czechia, Turkey, Malaysia, South Africa, Bulgaria, Poland, Hungary, Argentina, Brazil, Colombia, Japan, Mexico, Puerto Rico, Spain, Thailand, Ukraine, India
Fundação de Medicina Tropical Dr. Heitor Vieira...

Completed

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 (MetCOVID)

SARS-CoV Infection | Severe Acute Respiratory Syndrome (SARS) Pneumonia

Brazil
CureVac

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus
Instituto Nacional de Enfermedades Respiratorias

Terminated

Glycine Supplement for Severe COVID-19

COVID-19 | Pneumonia, Viral | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome) | ARDS, Human | SARS Pneumonia

Mexico
Meshalkin Research Institute of Pathology of Circulation

Unknown

SARS-CoV-2 Disguise Study (Disguise)

Sars-CoV2

Russian Federation
Pfizer

Suspended

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

COVID-19

United States, United Kingdom, Japan, South Africa, Bulgaria, Puerto Rico, Mexico, Hungary
LumiraDx UK Limited

Not yet recruiting

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)

SARS-CoV-2 | Influenza A | Asymptomatic COVID-19 | Influenza B

United States
Pfizer

Completed

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Healthy

United States
Novafem

Completed

Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.

SARS-CoV-2 Infection | Ovarian Reserve | Blastocyst

Colombia
Laboratorios Silanes S.A. de C.V.

Withdrawn

Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2 (DMMETCOV19)

Metabolic Syndrome | Type 2 Diabetes | Severe Acute Respiratory Syndrome Coronavirus 2

Mexico
Federal Research Clinical Center of Federal Medical...

Completed

The Efficacy of Vitamin D Supplementation in Patients With Severe and Extremely Severe COVID-19 (COVID-VIT)

SARS-CoV2 Infection

Russian Federation
Pine Trees, Inc.
Piedmont Healthcare; ICON plc; MRI Global; ASCLEPES Research Center; Eastside Research... and other collaborators

Completed

A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-Care

Covid19 | SARS (Severe Acute Respiratory Syndrome)

United States
Hospital de Infecciosas Francisco Javier Muniz

Completed

Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma

Covid19 | SARS-CoV Infection | SARS-Associated Coronavirus

Argentina
DILEK SAYIK

Unknown

Turkish of the SARS-CoV-2 Anxiety Scale

Anxiety | SARS-CoV Infection

Turkey
University of Sao Paulo General Hospital

Recruiting

Exploratory Study: COVID-19 and Pregnancy

Covid19 | Pregnant Women

Brazil
BioNTech SE
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Completed

Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population

SARS-CoV-2

China

Search clinical trials for: Schweres akutes respiratorisches Syndrom (SARS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Netherlands

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations